Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05741333Not ApplicableActive Not Recruiting

In-Office Clinical Study of the Solo+ TTD

Role: lead

NCT07029997Not Yet Recruiting

Post-Market Clinical Follow-Up Study of the Solo+ Tympanostomy Tube Device

Role: lead

NCT04148417Not ApplicableUnknown

Clinical Study of the Solo+ Tympanostomy Tube Device

Role: lead

NCT03722160Not ApplicableUnknown

Clinical Study of the Solo Tympanostomy Tube Device

Role: lead

NCT02957578Not ApplicableUnknown

Clinical Study of Solo Tympanostomy Tube Device (TTD)

Role: collaborator

All 5 trials loaded